Skip to Content

PLAQUENIL (Hydroxychloroquine Sulfate 200 mg)

Pill with imprint PLAQUENIL is White, Figure eight-shape and has been identified as Hydroxychloroquine Sulfate 200 mg. It is supplied by Sanofi-Synthelabo Inc.

Hydroxychloroquine is used in the treatment of lyme disease, arthritis; dermatomyositis; malaria prevention; malaria; rheumatoid arthritis and belongs to the drug classes antimalarial quinolines, antirheumatics. FDA has not classified the drug for risk during pregnancy. Hydroxychloroquine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PLAQUENIL

Hydroxychloroquine sulfate 200 mg PLAQUENIL
Hydroxychloroquine sulfate 200 mg PLAQUENIL
Hydroxychloroquine sulfate 200 mg PLAQUENIL
Hydroxychloroquine sulfate 200 mg PLAQUENIL

Hydroxychloroquine Sulfate

Imprint
PLAQUENIL
Strength
200 mg
Color
White
Shape
Figure eight-shape
Availability
Prescription only
Drug Class
Antimalarial quinolines, Antirheumatics
Pregnancy Category
N - Not classified
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sanofi-Synthelabo Inc
National Drug Code (NDC)
00955-0790

Get help with Imprint Code FAQs.

Related Images for "PLAQUENIL"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.